Cargando…
P1668: SYNERGY OF RED BLOOD CELLS AND TRANEXAMIC ACID IN THE INHIBITION OF FIBRINOLYSIS
Autores principales: | Raska, A., Kalman, K., Egri, B., Roberts, I., Kolev, K., Wohner, N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430036/ http://dx.doi.org/10.1097/01.HS9.0000849528.98716.da |
Ejemplares similares
-
Comparison of the effects of tranexamic acid, aprotinin and placebo on blood
conservation, fibrinolysis and platelet function with extensive heart surgery
por: Demeyere, R, et al.
Publicado: (2006) -
What concentration of tranexamic acid is needed to inhibit fibrinolysis? A systematic review of pharmacodynamics studies
por: Picetti, Roberto, et al.
Publicado: (2019) -
Computational model of tranexamic acid on urokinase mediated fibrinolysis
por: Wu, Tie Bo, et al.
Publicado: (2020) -
P1668: NON-APOPTOTIC CIRCULATING MICROPARTICLES ARE INVERSELY ASSOCIATED WITH PROCOAGULANT BIOMARKERS IN PATIENTS WITH ACUTE CORONARY SYNDROMES
por: Pallantza, Zoi, et al.
Publicado: (2023) -
The municipality of Paris confronts the plague of 1668.
por: Trout, A P
Publicado: (1973)